Issue Date: August 24, 2009
Neglected Disease Consortium Formed
A team of scientists from industry, academia, and the nonprofit sector are collaborating to find new treatments for African sleeping sickness and leishmaniasis, two neglected tropical diseases that kill a total of 100,000 people each year. The consortium, which is starting out with $5 million to be distributed over the course of four years, includes IOTA Pharmaceuticals, Mercachem, Nycomed, the Drugs for Neglected Diseases Initiative, the
To view the rest of this content, please log in with your ACS ID.